Zetia

FDA Warns About Zocor And Muscle Damage

19 Comments

Results Of Merck’s Vytorin Trial Delayed A Year

7 Comments

Vytorin Is Unlikely To Cause Cancer: FDA

6 Comments

The Vytorin Limbo: How Low Can You Go?

6 Comments

Whytorin? HHS Spends Millions On The Drug

4 Comments

The Arbiter Study Is Another Setback For Merck

14 Comments

Whytorin? Merck Cholesterol Pills Face Another Test

3 Comments

The Vytorin Limbo: Prescriptions Decline Again

1 Comment

Vytorin: A Top Ten Public Relations Blunder

2 Comments

Merck: The Outlook Is… Not So Good

2 Comments

Clear

Clear

All rights reserved, Nojasa LLC. Copyright, Nojasa LLC.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/